1. Home
  2. HXHX vs AEMD Comparison

HXHX vs AEMD Comparison

Compare HXHX & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Haoxin Holdings Limited Class A Ordinary Shares

HXHX

Haoxin Holdings Limited Class A Ordinary Shares

HOLD

Current Price

$0.17

Market Cap

4.7M

Sector

Industrials

ML Signal

HOLD

Logo Aethlon Medical Inc.

AEMD

Aethlon Medical Inc.

SELL

Current Price

$5.55

Market Cap

3.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
HXHX
AEMD
Founded
2003
1984
Country
China
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
3.9M
IPO Year
2022
2008

Fundamental Metrics

Financial Performance
Metric
HXHX
AEMD
Price
$0.17
$5.55
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
★ $13.25
AVG Volume (30 Days)
★ 739.5K
49.5K
Earning Date
11-24-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.96
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.12
$0.53
52 Week High
$1.36
$25.66

Technical Indicators

Market Signals
Indicator
HXHX
AEMD
Relative Strength Index (RSI) 36.55 53.20
Support Level N/A $4.86
Resistance Level $0.22 $6.09
Average True Range (ATR) 0.02 0.36
MACD 0.01 -0.02
Stochastic Oscillator 43.78 47.69

Price Performance

Historical Comparison
HXHX
AEMD

About HXHX Haoxin Holdings Limited Class A Ordinary Shares

Haoxin Holdings Ltd is a China-based logistics company engaged in temperature-controlled transportation and urban delivery services. The company provides cold chain logistics, freight forwarding, and related transportation services for goods, including new energy materials, electronic products, pharmaceuticals, meat, fruits, and vegetables. Its principal revenue streams are temperature-controlled truckload services and urban delivery services.

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.

Share on Social Networks: